BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 34175645)

  • 21. Guillain-Barré Syndrome Associated with SARS CoV-2 Infection: Case Report.
    Nigatu D; Tigabu T; Awraris M; Yohannes A; Kebede D
    Ethiop J Health Sci; 2022 Jan; 32(1):205-208. PubMed ID: 35250231
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Case Report: Four cases of SARS-CoV-2-associated Guillain-Barré Syndrome with SARS-CoV-2-positive cerebrospinal fluid detected by metagenomic next-generation sequencing: a retrospective case series from China.
    Guan Y; Yu C; Fei Y; Wang Q; Wang P; Zuo W; Wu H; Qi X; Shi Q
    Front Immunol; 2023; 14():1258579. PubMed ID: 37701436
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A case of Guillain-Barré syndrome related to COVID-19 infection.
    Türk Börü Ü; Köseoğlu Toksoy C; Bölük C; Demirbaş H; Yılmaz AÇ
    Int J Neurosci; 2023 Jan; 133(1):86-88. PubMed ID: 33535007
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Guillain-Barré syndrome presenting with COVID-19 infection.
    Ameer N; Shekhda KM; Cheesman A
    BMJ Case Rep; 2020 Sep; 13(9):. PubMed ID: 32928835
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of Guillain-Barre Syndrome With COVID-19: A Case Report and Literature Review.
    Singh R; Shiza ST; Saadat R; Dawe M; Rehman U
    Cureus; 2021 Mar; 13(3):e13828. PubMed ID: 33854850
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Concomitant Guillain-Barre syndrome with COVID-19: a case report.
    Mackenzie N; Lopez-Coronel E; Dau A; Maloof D; Mattar S; Garcia JT; Fontecha B; Lanata CM; Guillen-Burgos HF
    BMC Neurol; 2021 Mar; 21(1):135. PubMed ID: 33757457
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Rare Axonal Variant of Guillain-Barré Syndrome as a Neurological Complication of COVID-19 Infection.
    Agha Abbaslou M; Karbasi M; Mozhdehipanah H
    Arch Iran Med; 2020 Oct; 23(10):718-721. PubMed ID: 33107316
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Finger Drop-Dominant Variant of Guillain-Barre Syndrome in a Patient With COVID-19: A Case Report.
    Kang M; Seok HY
    J Korean Med Sci; 2022 May; 37(20):e160. PubMed ID: 35607739
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Guillain-Barré syndrome following the first dose of Pfizer-BioNTech COVID-19 vaccine: case report and review of reported cases.
    Bouattour N; Hdiji O; Sakka S; Fakhfakh E; Moalla K; Daoud S; Farhat N; Damak M; Mhiri C
    Neurol Sci; 2022 Feb; 43(2):755-761. PubMed ID: 34796417
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Concomitant Guillain-Barré syndrome and cerebral venous thrombosis complicating a SARS-CoV-2 infection: a case report.
    Qorchi H; Kissani N; Chraa M
    Pan Afr Med J; 2022; 42():212. PubMed ID: 36845246
    [TBL] [Abstract][Full Text] [Related]  

  • 31. COVID-19-induced Guillain-Barre Syndrome: A Rare Complication of SARS-CoV-2 Infection.
    Hanif M; Khan AW; Khan MA; Sundas F; Khan SJ
    J Coll Physicians Surg Pak; 2021 Jul; 31(7):S123-S124. PubMed ID: 34271810
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Guillain-Barré syndrome as a parainfectious manifestation of SARS-CoV-2 infection: A case series.
    Abolmaali M; Heidari M; Zeinali M; Moghaddam P; Ramezani Ghamsari M; Jamshidi Makiani M; Mirzaasgari Z
    J Clin Neurosci; 2021 Jan; 83():119-122. PubMed ID: 33281050
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Bifacial weakness with paresthesia – a rare Guillain–Barré syndrome subtype associated with SARS-CoV-2 infection].
    Gaál T; Szeszák G; Torák G; Salacz P
    Orv Hetil; 2021 Nov; 162(45):1803-1807. PubMed ID: 34747359
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A unique case of Miller Fisher-Guillain-Barré overlap syndrome in a liver transplant recipient.
    Ramirez-Sanchez C; Syed R; Meier A; LaBuzetta JN; Hylton DJ; Taremi M
    J Neurovirol; 2021 Oct; 27(5):797-801. PubMed ID: 34550544
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A variant of Guillain-Barre syndrome after SARS-CoV-2 vaccination: AMSAN.
    Tutar NK; Eyigürbüz T; Yildirim Z; Kale N
    Ideggyogy Sz; 2021 Jul; 74(7-08):286-288. PubMed ID: 34370408
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Late onset of Guillain-Barré syndrome following SARS-CoV-2 infection: part of 'long COVID-19 syndrome'?
    Raahimi MM; Kane A; Moore CE; Alareed AW
    BMJ Case Rep; 2021 Jan; 14(1):. PubMed ID: 33462068
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Rare Case of Guillain-Barré Syndrome Associated With SARS-CoV-2 Infection Requiring Mechanical Ventilation.
    Rane RP; Jain A; Hussain KM; Naik S; Shahab A
    Cureus; 2022 Jun; 14(6):e25810. PubMed ID: 35720780
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Botulism mimicking Guillain-Barre syndrome: The question of plasma exchange in an unusual case of acute paralysis.
    Silva Campos JJ; Abels E; Rinder HM; Tormey CA; Jacobs JW
    J Clin Apher; 2023 Dec; 38(6):760-763. PubMed ID: 37519071
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SARS-CoV-2 associated Guillain-Barré syndrome.
    Pelea T; Reuter U; Schmidt C; Laubinger R; Siegmund R; Walther BW
    J Neurol; 2021 Apr; 268(4):1191-1194. PubMed ID: 32770414
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma exchange for Guillain-Barré syndrome.
    Raphaël JC; Chevret S; Hughes RA; Annane D
    Cochrane Database Syst Rev; 2002; (2):CD001798. PubMed ID: 12076424
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.